/Investor DB

Richard King Mellon Foundation — 2025 Investments

3 investments dated 2025 · listed companies and verified rows first · show all

Earfloearflocare.comin𝕏Nov 2025

Earflo develops a non-invasive home treatment device for negative middle ear pressure in children, addressing a common pediatric condition that affects millions of children annually.

Digital HealthHardwareHealthtechMedical DevicesPerth, AU

Dr. Intan Oldakowski(Co-founder)Dr. Matthew Oldakowski(Co-founder)Dr. Peter Santa Maria(Co-founder, Chief Medical Officer)Dr. Stephen Kargotich(Co-founder)

Co-investorsMelt VenturesPerth Angels

SetPoint Medicalsetpointmedical.comin𝕏Sep 2025 · $140M

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

Murthy Simhambhatla(CEO)inDavid Chernoff(Chief Medical Officer (MD))Yaakov Levine(PhD)inRohan Seth(Executive Officer)inKevin Tracey(Founder)

BoardBlake Wu(Director)in

Co-investorsAlly Bridge GroupNew Enterprise Associates (NEA)Norwest Venture PartnersTopspin PartnersAsahi Kasei Corporate Venture CapitalCatalio Capital Management, LP+12 more

Surface Design Solutionssurface.designinSep 2025

Surface Design Solutions offers Surface Designer, a physics-informed AI software platform paired with expert analysis services that help manufacturers optimize the surfaces of parts and tooling.

Advanced ManufacturingAI & Machine LearningDeep TechPittsburgh, US

Luke Thimons(Secretary and Director)inTevis Jacobs(President, Treasurer and Director)inJohannes H?rmann(Secretary and Director of Issuer)Lars Pastewka(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.